-
No Radiotherapy, No MRI, No Money: Uganda’s Health Funding Crisis
Monday 11 April was not a normal day in the radiotherapy clinic at the Mulago National Referral hospital in Kampala.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
-
Weekly Roundup: Healthy Debate and Unhealthy Economics at Unite for Sight
I went to a global health conference last weekend and an economics lesson broke out. OK, that’s a bit of an oversimplification. A lot more than economics was discussed at the 13th annual Unite for Sight Global Health & Innovation Conference at Yale University. It’s just that as I scurried from session to session around the campus, I kept hearing about the scarcity and/or misapplication of money.
- Categories
- Health Care, Impact Assessment
- Tags
- public health
-
J&J Ebola Vaccine Has Promise as Wider Test Awaits Next Outbreak
An experimental Ebola vaccine from Johnson & Johnson, boosted by a second immunization shot from biotechnology company Bavarian Nordic A/S, generated a powerful immune response among volunteers in its first tests in humans.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
- Tags
- vaccines
-
‘India Makes All Mylan HIV Drugs for Developing World’
Rajiv Malik is president of Mylan, the $9.5-billion, Nasdaq-listed global generic and speciality pharmaceuticals company. Malik became part of Mylan in 2007 when the latter acquired India-based Matrix Laboratories, where he was CEO. That deal also transformed Mylan, which till then operated only in the US, into one of the world's largest manufacturers of active pharmaceutical ingredients (APIs). On a recent visit to Bengaluru, Malik spoke to TOI:
- Categories
- Health Care
- Region
- South Asia
-
A New Blood Test for Tuberculosis Could Save Millions of Lives
As much as one third of the global population is currently infected with the bacterium that causes tuberculosis (TB), a disease typically concentrated in the lungs and characterized by weakness, fever, coughing and chest pain. About 9.6 million new infections occurred in 2014, the most recent year for which numbers are available. Roughly 1.5 million people died of TB that same year. The ability to easily, inexpensively and accurately diagnose TB is of utmost importance, but the most commonly used method fails, at least to some extent, on all three counts. A new blood-based technique might considerably rein in this epidemic.
- Categories
- Health Care
- Region
- South Asia
-
1mg Gets $16 Million Series B to Make India’s Health Industry More Transparent
India’s pharmaceutical market is filled with generic options—but they don’t always save consumers money. In fact, some drugs are even more expensive than their branded counterparts. Created to give patients more power over their health costs, startup 1mg announced today that it has raised a $16 million Series B led by Maverick Capital Ventures, with participation from returning investors Sequoia India and Omidiyar Network.
- Categories
- Health Care
- Region
- South Asia
-
Abell Foundation Invests in Baltimore Medical Device Maker
The Abell Foundation has invested $200,000 in Sisu Global Health, a Baltimore-based company that's developing medical devices for doctors in the developing world.
- Categories
- Health Care
-
India’s Health Challenges and Would-Be Solutions – From Human to Artificial Intelligence
By 2030, India's population of people age 60 or older is projected to grow by 64 percent while urban areas are expected to more than double their current population levels. A massive shift from from communicable diseases to non-communicable diseases is coming, creating different health care challenges. Villgro, a Chennai-based social business incubator, sees many opportunities for social entrepreneurs developing tech-based solutions.
- Categories
- Health Care